Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphoric ester hydrolase activity	PPP4R1 TPTE MYH3 MYH6 CASR NT5C3B PTK2 INPP4B SSH3 PLCH1 TNS1 PHLPP2	7.64e-05	386	162	12	GO:0042578
GeneOntologyMolecularFunction	hydrolase activity, acting on ester bonds	PPP4R1 TPTE MYH3 MYH6 DIS3L2 ERN1 SGSH CASR NT5C3B ERI2 PTK2 INPP4B SSH3 AADACL2 PLA2G4A PLCH1 TNS1 PHLPP2	1.01e-04	807	162	18	GO:0016788
GeneOntologyMolecularFunction	phosphatase activity	PPP4R1 TPTE MYH3 MYH6 NT5C3B PTK2 INPP4B SSH3 TNS1 PHLPP2	1.22e-04	287	162	10	GO:0016791
GeneOntologyMolecularFunction	actin binding	MYH2 MYH3 MYH6 NRAP MYLK SPTBN1 PTK2 SSH3 SYNE2 KCNMA1 PLEC TNS1 MYO16	1.50e-04	479	162	13	GO:0003779
GeneOntologyMolecularFunction	phosphoprotein phosphatase activity	PPP4R1 TPTE MYH3 MYH6 PTK2 SSH3 TNS1 PHLPP2	1.59e-04	189	162	8	GO:0004721
GeneOntologyMolecularFunction	histone H2AXS139 kinase activity	ATR PRKDC	1.95e-04	3	162	2	GO:0035979
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH2 MYH3 MYH6 DNAH1 MYO16 DYNC1H1	4.05e-04	118	162	6	GO:0003774
GeneOntologyMolecularFunction	histone H2AX kinase activity	ATR PRKDC	6.44e-04	5	162	2	GO:0141003
Domain	ARM-type_fold	PPP4R1 NCAPD3 ATR MROH5 ZYG11B MEI1 FOCAD URB1 THADA NF1 NCAPD2 PRKDC AP4B1	8.44e-06	339	162	13	IPR016024
Domain	ARM-like	PPP4R1 NCAPD3 ATR MROH5 ZYG11B MEI1 NF1 NCAPD2 PRKDC AP4B1 MED12	2.45e-05	270	162	11	IPR011989
Domain	-	PPP4R1 NCAPD3 ATR MROH5 ZYG11B NF1 NCAPD2 PRKDC AP4B1 MED12	2.46e-05	222	162	10	1.25.10.10
Domain	HEAT	PPP4R1 NCAPD3 ATR NCAPD2 PRKDC	5.85e-05	48	162	5	PF02985
Domain	CND1/NCAPD3	NCAPD3 NCAPD2	7.48e-05	2	162	2	IPR026971
Domain	Cnd1	NCAPD3 NCAPD2	7.48e-05	2	162	2	PF12717
Domain	Cnd1_C	NCAPD3 NCAPD2	7.48e-05	2	162	2	IPR032682
Domain	Spectrin_repeat	SPTBN1 SYNE2 PLEC MCF2L	1.09e-04	29	162	4	IPR002017
Domain	HEAT	PPP4R1 NCAPD3 ATR NCAPD2 PRKDC	1.46e-04	58	162	5	IPR000357
Domain	SPEC	SPTBN1 SYNE2 PLEC MCF2L	1.62e-04	32	162	4	SM00150
Domain	Spectrin/alpha-actinin	SPTBN1 SYNE2 PLEC MCF2L	1.62e-04	32	162	4	IPR018159
Domain	ATPase_dyneun-rel_AAA	DNAH1 MDN1 DYNC1H1	2.17e-04	14	162	3	IPR011704
Domain	AAA_5	DNAH1 MDN1 DYNC1H1	2.17e-04	14	162	3	PF07728
Domain	K_chnl_volt-dep_ELK	KCNH8 KCNH3	2.23e-04	3	162	2	IPR003950
Domain	Myosin_N	MYH2 MYH3 MYH6	2.70e-04	15	162	3	PF02736
Domain	Myosin_N	MYH2 MYH3 MYH6	2.70e-04	15	162	3	IPR004009
Domain	Myosin_head_motor_dom	MYH2 MYH3 MYH6 MYO16	3.20e-04	38	162	4	IPR001609
Domain	MYOSIN_MOTOR	MYH2 MYH3 MYH6 MYO16	3.20e-04	38	162	4	PS51456
Domain	Myosin_head	MYH2 MYH3 MYH6 MYO16	3.20e-04	38	162	4	PF00063
Domain	MYSc	MYH2 MYH3 MYH6 MYO16	3.20e-04	38	162	4	SM00242
Domain	Pecanex_C	PCNX3 PCNX4	4.44e-04	4	162	2	PF05041
Domain	Pecanex	PCNX3 PCNX4	4.44e-04	4	162	2	IPR007735
Domain	Myosin_tail_1	MYH2 MYH3 MYH6	4.75e-04	18	162	3	PF01576
Domain	Myosin_tail	MYH2 MYH3 MYH6	4.75e-04	18	162	3	IPR002928
Domain	Ion_trans_dom	TPTE KCNH8 RYR2 KCNH3 CATSPER4 KCNMA1	4.78e-04	114	162	6	IPR005821
Domain	Ion_trans	TPTE KCNH8 RYR2 KCNH3 CATSPER4 KCNMA1	4.78e-04	114	162	6	PF00520
Domain	-	MXRA5 NAIP ZYG11B LINGO2 TLR7 SKP2 FBXL21P PRELP SLIT3 PHLPP2	5.06e-04	321	162	10	3.80.10.10
Domain	Myosin-like_IQ_dom	MYH2 MYH3 MYH6	5.60e-04	19	162	3	IPR027401
Domain	-	MYH2 MYH3 MYH6	5.60e-04	19	162	3	4.10.270.10
Domain	L_dom-like	MXRA5 NAIP ZYG11B LINGO2 TLR7 SKP2 FBXL21P PRELP SLIT3 PHLPP2	5.98e-04	328	162	10	IPR032675
Domain	FATC	ATR PRKDC	7.35e-04	5	162	2	PF02260
Domain	Spectrin	SPTBN1 SYNE2 MCF2L	9.99e-04	23	162	3	PF00435
Domain	ACTININ_2	SPTBN1 SYNE2 PLEC	9.99e-04	23	162	3	PS00020
Domain	ACTININ_1	SPTBN1 SYNE2 PLEC	9.99e-04	23	162	3	PS00019
Domain	Actinin_actin-bd_CS	SPTBN1 SYNE2 PLEC	9.99e-04	23	162	3	IPR001589
Domain	zf-C2H2	ZNF131 ZFAT ZNF234 ZNF280D ZNF781 ZNF813 MECOM ZNF275 ZNF829 ZNF276 ZNF827 ZBTB40 ZNF574 ZNF646 ZNF662	1.05e-03	693	162	15	PF00096
Domain	FAT	ATR PRKDC	1.10e-03	6	162	2	PS51189
Domain	FATC	ATR PRKDC	1.10e-03	6	162	2	PS51190
Domain	FAT	ATR PRKDC	1.10e-03	6	162	2	PF02259
Domain	PIK-rel_kinase_FAT	ATR PRKDC	1.10e-03	6	162	2	IPR003151
Domain	FATC_dom	ATR PRKDC	1.10e-03	6	162	2	IPR003152
Domain	PIK_FAT	ATR PRKDC	1.10e-03	6	162	2	IPR014009
Domain	FATC	ATR PRKDC	1.10e-03	6	162	2	SM01343
Domain	ZINC_FINGER_C2H2_2	ZNF131 ZFAT ZNF234 ZNF280D ZNF781 ZNF813 MECOM ZNF275 ZNF829 ZNF276 WIZ ZNF827 ZBTB40 ZNF574 ZNF646 ZNF662	1.17e-03	775	162	16	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF131 ZFAT ZNF234 ZNF280D ZNF781 ZNF813 MECOM ZNF275 ZNF829 ZNF276 WIZ ZNF827 ZBTB40 ZNF574 ZNF646 ZNF662	1.21e-03	777	162	16	PS00028
Domain	PAC	NCOA2 KCNH8 KCNH3	1.44e-03	26	162	3	IPR001610
Domain	PAC	NCOA2 KCNH8 KCNH3	1.44e-03	26	162	3	SM00086
Domain	LRRNT	MXRA5 LINGO2 TLR7 PRELP SLIT3	1.64e-03	98	162	5	IPR000372
Domain	LRRNT	MXRA5 LINGO2 TLR7 PRELP SLIT3	1.64e-03	98	162	5	SM00013
Domain	Znf_C2H2	ZNF131 ZFAT ZNF234 ZNF280D ZNF781 ZNF813 MECOM ZNF275 ZNF829 ZNF276 WIZ ZNF827 ZBTB40 ZNF574 ZNF646 ZNF662	1.73e-03	805	162	16	IPR007087
Domain	ZnF_C2H2	ZNF131 ZFAT ZNF234 ZNF280D ZNF781 ZNF813 MECOM ZNF275 ZNF829 ZNF276 WIZ ZNF827 ZBTB40 ZNF574 ZNF646 ZNF662	1.80e-03	808	162	16	SM00355
Domain	PTEN_C2	TPTE TNS1	2.02e-03	8	162	2	PF10409
Domain	PTEN_C2	TPTE TNS1	2.02e-03	8	162	2	SM01326
Domain	C2_TENSIN	TPTE TNS1	2.02e-03	8	162	2	PS51182
Domain	Tensin_lipid_phosphatase_dom	TPTE TNS1	2.02e-03	8	162	2	IPR029023
Domain	Tensin_C2-dom	TPTE TNS1	2.02e-03	8	162	2	IPR014020
Domain	CH	SPTBN1 SYNE2 NAV3 PLEC	2.45e-03	65	162	4	SM00033
Domain	Leu-rich_rpt	MXRA5 ZYG11B LINGO2 TLR7 SKP2 PRELP SLIT3 PHLPP2	2.56e-03	271	162	8	IPR001611
Domain	PPASE_TENSIN	TPTE TNS1	2.59e-03	9	162	2	PS51181
Domain	CNMP_BINDING_1	KCNH8 KCNH3 RAPGEF3	2.64e-03	32	162	3	PS00888
Domain	CNMP_BINDING_2	KCNH8 KCNH3 RAPGEF3	2.64e-03	32	162	3	PS00889
Domain	C2_dom	TPTE INPP4B PLA2G4A PLCH1 TNS1 UVRAG	3.10e-03	164	162	6	IPR000008
Domain	cNMP	KCNH8 KCNH3 RAPGEF3	3.15e-03	34	162	3	SM00100
Domain	PAS	NCOA2 KCNH8 KCNH3	3.15e-03	34	162	3	PS50112
Domain	PAS	NCOA2 KCNH8 KCNH3	3.15e-03	34	162	3	IPR000014
Domain	cNMP_binding	KCNH8 KCNH3 RAPGEF3	3.15e-03	34	162	3	PF00027
Domain	CH	SPTBN1 SYNE2 NAV3 PLEC	3.21e-03	70	162	4	PF00307
Domain	HEAT_REPEAT	PPP4R1 NCAPD3 ATR PRKDC	3.21e-03	70	162	4	PS50077
Domain	PAS_9	KCNH8 KCNH3	3.21e-03	10	162	2	PF13426
Domain	-	SPTBN1 SYNE2 NAV3 PLEC	3.37e-03	71	162	4	1.10.418.10
Domain	cNMP-bd_dom	KCNH8 KCNH3 RAPGEF3	3.42e-03	35	162	3	IPR000595
Domain	CNMP_BINDING_3	KCNH8 KCNH3 RAPGEF3	3.42e-03	35	162	3	PS50042
Domain	CH	SPTBN1 SYNE2 NAV3 PLEC	3.73e-03	73	162	4	PS50021
Domain	LRR_8	MXRA5 LINGO2 TLR7 PRELP SLIT3 PHLPP2	3.81e-03	171	162	6	PF13855
Domain	Znf_C2H2-like	ZNF131 ZFAT ZNF234 ZNF280D ZNF781 ZNF813 MECOM ZNF829 ZNF276 WIZ ZNF827 ZBTB40 ZNF574 ZNF646 ZNF662	3.97e-03	796	162	15	IPR015880
Domain	PH_dom-like	SPTBN1 SHC3 PTK2 FRMD6 ARHGEF1 MCF2L PLCH1 TNS1 PHLPP2 SOS2	4.10e-03	426	162	10	IPR011993
Domain	CH-domain	SPTBN1 SYNE2 NAV3 PLEC	4.11e-03	75	162	4	IPR001715
Domain	cNMP-bd-like	KCNH8 KCNH3 RAPGEF3	4.33e-03	38	162	3	IPR018490
Domain	LRR_TYP	MXRA5 LINGO2 TLR7 PRELP SLIT3 PHLPP2	4.51e-03	177	162	6	SM00369
Domain	Leu-rich_rpt_typical-subtyp	MXRA5 LINGO2 TLR7 PRELP SLIT3 PHLPP2	4.51e-03	177	162	6	IPR003591
Domain	GDS_CDC24_CS	ARHGEF1 MCF2L SOS2	4.66e-03	39	162	3	IPR001331
Domain	FAD-dep_OxRdtase	KMO PCYOX1	4.66e-03	12	162	2	IPR006076
Domain	CRAL_TRIO_2	NF1 MCF2L	4.66e-03	12	162	2	PF13716
Domain	DAO	KMO PCYOX1	4.66e-03	12	162	2	PF01266
Domain	GRIP_dom	TRIP11 GOLGA4	4.66e-03	12	162	2	IPR000237
Domain	GRIP	TRIP11 GOLGA4	4.66e-03	12	162	2	PS50913
Domain	DUF4599	SPATA31D4 SPATA31D3	4.66e-03	12	162	2	PF15371
Domain	DUF4599	SPATA31D4 SPATA31D3	4.66e-03	12	162	2	IPR027970
Domain	IQ	MYH2 MYH3 MYH6 MYO16	5.41e-03	81	162	4	SM00015
Domain	-	ZNF131 ZFAT ZNF234 ZNF781 ZNF813 MECOM ZNF829 ZNF276 ZNF827 ZBTB40 ZNF574 ZNF646 ZNF662	6.33e-03	679	162	13	3.30.160.60
Domain	Dynein_heavy_chain_D4_dom	DNAH1 DYNC1H1	6.35e-03	14	162	2	IPR024317
Domain	Dynein_HC_stalk	DNAH1 DYNC1H1	6.35e-03	14	162	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH1 DYNC1H1	6.35e-03	14	162	2	IPR013602
Domain	DHC_N2	DNAH1 DYNC1H1	6.35e-03	14	162	2	PF08393
Domain	Ras_G-nucl-exch_fac_CS	RAPGEF3 SOS2	6.35e-03	14	162	2	IPR019804
Domain	K_chnl_volt-dep_EAG/ELK/ERG	KCNH8 KCNH3	6.35e-03	14	162	2	IPR003938
Domain	MT	DNAH1 DYNC1H1	6.35e-03	14	162	2	PF12777
Domain	AAA_8	DNAH1 DYNC1H1	6.35e-03	14	162	2	PF12780
Domain	-	SPTBN1 SHC3 FRMD6 ARHGEF1 MCF2L PLCH1 TNS1 PHLPP2 SOS2	7.20e-03	391	162	9	2.30.29.30
Domain	DHC_fam	DNAH1 DYNC1H1	7.29e-03	15	162	2	IPR026983
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NCOA2 MYH2 NCAPD3 MXRA5 WDR64 ACACB URB2 RFC1 HM13 TRIP11 RYR2 TTBK2 RAB3GAP1 NF1 MDN1 PRELP SYNE2 MCF2L KNL1	3.02e-10	638	167	19	31182584
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NCAPD3 ATR SPTBN1 SIN3A RFC1 PITPNM1 STK10 NF1 MDN1 ANAPC1 ZBTB40 TRAPPC10 PLA2G4A ACIN1 PRKDC PLEC DHX29 GOLGA4 TP53BP1	7.14e-09	774	167	19	15302935
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PCNX3 ICE1 KCNH3 FOCAD CCNE1 STK10 URB1 THADA ZNF276 MDN1 WIZ ZNF827 PCNX4 NCAPD2 LRP4 PRKDC ATG9A PLEC MCF2L UVRAG MED12 DYNC1H1	1.89e-08	1105	167	22	35748872
Pubmed	Analysis of Expression of the ANG1, CaSR and FAK Proteins in Uterine Fibroids.	ANGPT1 CASR PTK2	1.09e-07	3	167	3	39000274
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	ATR SPTBN1 NF1 MDN1 WIZ BABAM1 ANAPC1 ARHGEF1 NCAPD2 ACIN1 PRKDC PLEC PCBP2 DYNC1H1 KNL1	1.60e-07	582	167	15	20467437
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MYH2 NCAPD3 SPTBN1 RFC1 FHIP2A SKP2 POLR3A CCNE1 RAB3GAP1 URB1 THADA NDC1 MDN1 SYNE2 NCAPD2 TRAPPC10 LRP4 ATP13A3 PRKDC STX16 PCBP2 DHX29 DYNC1H1	4.53e-07	1440	167	23	30833792
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	MYH2 MYH3 MYH6 SPTBN1 ZYG11B TTBK2 TGM2 THADA MDN1 NCAPD2 PRKDC PLEC PCBP2 DYNC1H1 TP53BP1	6.12e-07	647	167	15	26618866
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DIS3L2 SPTBN1 URB2 RFC1 PTK2 POLR3A TGM2 NAA35 RAB3GAP1 URB1 NF1 MDN1 ARHGEF1 NCAPD2 ACIN1 PRKDC PLEC DHX29 MED12 DYNC1H1 GOLGA4 TP53BP1	6.14e-07	1353	167	22	29467282
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	NCAPD3 SPTBN1 SIN3A MDN1 ANAPC1 NCAPD2 ACIN1 PRKDC PLEC DYNC1H1 TP53BP1	6.83e-07	332	167	11	32786267
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	SPTBN1 URB2 RFC1 URB1 NF1 MDN1 ANAPC1 SYNE2 NCAPD2 ACIN1 PRKDC PLEC MED12 DYNC1H1 TP53BP1	6.86e-07	653	167	15	22586326
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	NCAPD3 RFC1 NDC1 NF1 ANAPC1 NCAPD2 PRKDC PLEC KNL1	8.82e-07	210	167	9	16565220
Pubmed	Temporal regulation of the Mediator complex during muscle proliferation, differentiation, regeneration, aging, and disease.	MYH2 MYH3 MED23 MED7 MED12	1.21e-06	39	167	5	38690566
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	NCAPD3 ZNF280D ATR SPTBN1 URB2 RFC1 POLR3A URB1 THADA NDC1 NF1 MDN1 ANAPC1 NCAPD2 ACIN1 PRKDC MED23 STX16 DHX29 DYNC1H1 GOLGA4 PCYOX1	1.44e-06	1425	167	22	30948266
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	NCAPD3 SPTBN1 ZNF813 SIN3A ZNF275 DTX3L URB2 HM13 NAA35 NDC1 ANAPC1 NCAPD2 PRKDC PLEC MED23 STX16 MED12 TP53BP1 ZNF574 ZNF646	1.49e-06	1203	167	20	29180619
Pubmed	Phospholipase Cε hydrolyzes perinuclear phosphatidylinositol 4-phosphate to regulate cardiac hypertrophy.	RYR2 RAPGEF3 PLCH1	2.15e-06	6	167	3	23540699
Pubmed	NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.	RFC1 MDN1 WIZ ANAPC1 TRAPPC10 PRKDC MED23	3.17e-06	129	167	7	23022380
Pubmed	Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint.	ATR SKP2 PRKDC	3.75e-06	7	167	3	20818375
Pubmed	Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts.	MYH2 MYH3 MYH6	3.75e-06	7	167	3	16819597
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NCOA2 PPP4R1 ZNF234 SPTBN1 CEP57L1 ASH1L TRIP11 PTK2 FOCAD DGLUCY WIZ NAV3 LRP4 PRKDC PLEC TNKS2 PBX1 DYNC1H1 ZNF662 SOS2	4.01e-06	1285	167	20	35914814
Pubmed	Cloning and expression analysis of murine phospholipase D1.	MYH2 MECOM NF1	5.98e-06	8	167	3	9307024
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	NCAPD3 ATR ICE1 ANAPC1 NCAPD2 ANKRD30A PRKDC PLEC	6.48e-06	202	167	8	33005030
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	MYH2 MYH3 MYH6 MYLK ATR SIN3A SKP2 PTK2 CCNE1 STK10 NDC1 NF1 ANAPC1 PLEC TNS1 KNL1	8.91e-06	910	167	16	36736316
Pubmed	Analysis of recently identified osteoporosis susceptibility genes in Han Chinese women.	SPTBN1 ZBTB40 LRP4	1.27e-05	10	167	3	20554715
Pubmed	The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.	PPP4R1 SPTBN1 SYNE2 TNKS2	1.27e-05	30	167	4	30480076
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	NCAPD3 ATR ICE1 SIN3A MDN1 BABAM1 ZNF827 MED7 MED12 TP53BP1 KNL1	1.33e-05	453	167	11	29656893
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA2 SIN3A WIZ ANAPC1 NCAPD2 ACIN1 PRKDC MED23 PCBP2 MED12 DYNC1H1 TP53BP1	1.52e-05	549	167	12	38280479
Pubmed	Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.	NCAPD3 SIN3A MED23 MED7 MED12	1.70e-05	66	167	5	23275444
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	NCOA2 ZNF131 NCAPD3 MECOM SIN3A SKP2 MDN1 WIZ ANAPC1 NCAPD2 ZBTB40 PLA2G4A PBX1 DYNC1H1 TP53BP1	1.81e-05	857	167	15	25609649
Pubmed	Maintenance of silent chromatin through replication requires SWI/SNF-like chromatin remodeler SMARCAD1.	SIN3A ZNF829 MDN1 WIZ ANAPC1 PRKDC	2.15e-05	116	167	6	21549307
Pubmed	SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.	MECOM INPP4B	2.29e-05	2	167	2	29415082
Pubmed	Prognostic potential of KLOTHO and SFRP1 promoter methylation in head and neck squamous cell carcinoma.	SFRP1 KL	2.29e-05	2	167	2	28812223
Pubmed	Neurofibromin interacts with the cytoplasmic Dynein Heavy Chain 1 in melanosomes of human melanocytes.	NF1 DYNC1H1	2.29e-05	2	167	2	23583712
Pubmed	DNA structure-specific priming of ATR activation by DNA-PKcs.	ATR PRKDC	2.29e-05	2	167	2	23897887
Pubmed	Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population.	LILRB3 LILRA6	2.29e-05	2	167	2	33526815
Pubmed	Kv12-encoded K+ channels drive the day-night switch in the repetitive firing rates of SCN neurons.	KCNH8 KCNH3	2.29e-05	2	167	2	37516908
Pubmed	Arrhythmic effects of Epac-mediated ryanodine receptor activation in Langendorff-perfused murine hearts are associated with reduced conduction velocity.	RYR2 RAPGEF3	2.29e-05	2	167	2	28316073
Pubmed	Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase.	PTK2 NF1	2.29e-05	2	167	2	19479903
Pubmed	The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E.	SKP2 CCNE1	2.29e-05	2	167	2	11237742
Pubmed	Non-SMC condensin I complex subunit D2 and non-SMC condensin II complex subunit D3 induces inflammation via the IKK/NF-κB pathway in ulcerative colitis.	NCAPD3 NCAPD2	2.29e-05	2	167	2	31885422
Pubmed	Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells.	MECOM PBX1	2.29e-05	2	167	2	19767769
Pubmed	Neuronal migration defects in the Loa dynein mutant mouse.	DNAH1 DYNC1H1	2.29e-05	2	167	2	21612657
Pubmed	Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans.	LILRB3 LILRA6	2.29e-05	2	167	2	36449053
Pubmed	Angiopoietin1 contributes to the maintenance of cell quiescence in EVI1(high) leukemia cells.	ANGPT1 MECOM	2.29e-05	2	167	2	22033412
Pubmed	KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome.	PTK2 KCNMA1	2.29e-05	2	167	2	28231797
Pubmed	Focal adhesion kinase pp125FAK interacts with the large conductance calcium-activated hSlo potassium channel in human osteoblasts: potential role in mechanotransduction.	PTK2 KCNMA1	2.29e-05	2	167	2	14584897
Pubmed	Two pools of IRE1α in cardiac and skeletal muscle cells.	ERN1 RYR2	2.29e-05	2	167	2	31051095
Pubmed	The SCID mouse: an experimental model for endometriosis.	MKKS PRKDC	2.29e-05	2	167	2	10601104
Pubmed	Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients.	LILRB3 LILRA6	2.29e-05	2	167	2	19617579
Pubmed	Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair.	LILRB3 LILRA6	2.29e-05	2	167	2	24096970
Pubmed	A novel docking site on Mediator is critical for activation by VP16 in mammalian cells.	MED23 MED7 MED12	3.00e-05	13	167	3	14657022
Pubmed	Genomic analysis of mouse retinal development.	PCNX3 RFC1 SKP2 PTK2 RAB3GAP1 MPP4 SLIT3 NCAPD2 NAV3 ACIN1 PRKDC PLEC TNKS2 MCF2L PLCH1 PHLPP2	3.02e-05	1006	167	16	15226823
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZNF131 ZNF280D ACACB MECOM ICE1 WIZ ANAPC1 PLEC MED12 KNL1	3.74e-05	418	167	10	34709266
Pubmed	EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.	MECOM PRKDC PLEC PCBP2 DYNC1H1 TP53BP1	3.75e-05	128	167	6	23858473
Pubmed	Structure, function, and activator-induced conformations of the CRSP coactivator.	MED23 MED7 MED12	3.81e-05	14	167	3	11834832
Pubmed	Condensin I and II Complexes License Full Estrogen Receptor α-Dependent Enhancer Activation.	NCAPD3 DTX3L NCAPD2	3.81e-05	14	167	3	26166704
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	SPTBN1 NAIP PTK2 PITPNM1 KL NF1 KCNMA1 PLEC STX16	4.97e-05	347	167	9	17114649
Pubmed	Meta-analysis of genome-wide association studies of adult height in East Asians identifies 17 novel loci.	ZFAT DIS3L2 TRIP11 SLIT3 VGLL4 TNS1	5.26e-05	136	167	6	25429064
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	SPTBN1 MDN1 ANAPC1 PRKDC PLEC PCBP2 MED12 DYNC1H1	5.47e-05	272	167	8	31010829
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	TPTE KCNH8 GCNT3 MYLK PTK2 KCNH3 POLR3A SULT1E1 CCNE1 HDAC3 TGM2 SSH3 RPS6KA6	5.61e-05	730	167	13	34857952
Pubmed	Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes.	NCOA2 ATR TRIP11 ACIN1 TP53BP1	5.78e-05	85	167	5	16051665
Pubmed	DelK32-lamin A/C has abnormal location and induces incomplete tissue maturation and severe metabolic defects leading to premature death.	MYH3 MYH6 ACACB	5.82e-05	16	167	3	22090424
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	SPTBN1 TRIP11 ARHGEF1 ACIN1 PRKDC PLEC DYNC1H1 GOLGA4 TP53BP1	6.58e-05	360	167	9	33111431
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NCOA2 SPTBN1 TRIP11 PTK2 HDAC3 NF1 MDN1 WIZ ANAPC1 SYNE2 KCNMA1 TNS1 DYNC1H1 GOLGA4 TP53BP1	6.82e-05	963	167	15	28671696
Pubmed	Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.	ATR PRKDC	6.85e-05	3	167	2	9766667
Pubmed	Tagging single nucleotide polymorphisms in phosphoinositide-3-kinase-related protein kinase genes involved in DNA damage "checkpoints" and lung cancer susceptibility.	ATR PRKDC	6.85e-05	3	167	2	18451257
Pubmed	miR-181 elevates Akt signaling by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast cancer.	INPP4B PHLPP2	6.85e-05	3	167	2	28224609
Pubmed	Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro.	MYH3 MYH6	6.85e-05	3	167	2	1694848
Pubmed	DNA Damage Signaling Is Required for Replication of Human Bocavirus 1 DNA in Dividing HEK293 Cells.	ATR PRKDC	6.85e-05	3	167	2	27733644
Pubmed	Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment.	ANGPT1 PRKDC	6.85e-05	3	167	2	27960088
Pubmed	EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation.	RAPGEF3 PRKDC	6.85e-05	3	167	2	18728186
Pubmed	Silencing of long noncoding RNA MYLK-AS1 suppresses nephroblastoma via down-regulation of CCNE1 through transcription factor TCF7L2.	MYLK CCNE1	6.85e-05	3	167	2	33438217
Pubmed	Klotho restoration via acetylation of Peroxisome Proliferation-Activated Receptor γ reduces the progression of chronic kidney disease.	HDAC3 KL	6.85e-05	3	167	2	28416226
Pubmed	DNA-PKcs and ATM epistatically suppress DNA end resection and hyperactivation of ATR-dependent G2-checkpoint in S-phase irradiated cells.	ATR PRKDC	6.85e-05	3	167	2	31601897
Pubmed	Epac, Rap and Rab3 act in concert to mobilize calcium from sperm's acrosome during exocytosis.	RAB3GAP1 RAPGEF3	6.85e-05	3	167	2	25159528
Pubmed	Cyclin E1 expression and malignancy in meningiomas.	SKP2 CCNE1	6.85e-05	3	167	2	31945623
Pubmed	Radiation-dose-dependent functional synergisms between ATM, ATR and DNA-PKcs in checkpoint control and resection in G2-phase.	ATR PRKDC	6.85e-05	3	167	2	31164689
Pubmed	ATF4 and IRE1α inhibit DNA repair protein DNA-dependent protein kinase 1 induced by heat shock.	ERN1 PRKDC	6.85e-05	3	167	2	23001845
Pubmed	53BP1 Mediates ATR-Chk1 Signaling and Protects Replication Forks under Conditions of Replication Stress.	ATR TP53BP1	6.85e-05	3	167	2	29378830
Pubmed	Interrelated role of Klotho and calcium-sensing receptor in parathyroid hormone synthesis and parathyroid hyperplasia.	CASR KL	6.85e-05	3	167	2	29618612
Pubmed	γ-Tocopherol inhibits human prostate cancer cell proliferation by up-regulation of transglutaminase 2 and down-regulation of cyclins.	CCNE1 TGM2	6.85e-05	3	167	2	22460364
Pubmed	Neurofibromin binds to caveolin-1 and regulates ras, FAK, and Akt.	PTK2 NF1	6.85e-05	3	167	2	16405917
Pubmed	FAK in the nucleus prevents VSMC proliferation by promoting p27 and p21 expression via Skp2 degradation.	SKP2 PTK2	6.85e-05	3	167	2	33839758
Pubmed	Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study.	MYH3 MYH6	6.85e-05	3	167	2	1939265
Pubmed	Early effects of Epac depend on the fine-tuning of the sarcoplasmic reticulum Ca2+ handling in cardiomyocytes.	RYR2 RAPGEF3	6.85e-05	3	167	2	29037982
Pubmed	[Roles of DNA dependent protein kinase in silica-induced cyclin E and CDK2 expressions and cell cycle changes in human embryo lung fibroblasts].	CCNE1 PRKDC	6.85e-05	3	167	2	21941773
Pubmed	Knockdown of IRE1ɑ suppresses metastatic potential of colon cancer cells through inhibiting FN1-Src/FAK-GTPases signaling.	ERN1 PTK2	6.85e-05	3	167	2	31326465
Pubmed	Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells.	ATR PRKDC	6.85e-05	3	167	2	19444312
Pubmed	Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase.	ATR PRKDC	6.85e-05	3	167	2	26365377
Pubmed	Systematic dissection of dynein regulators in mitosis.	DNAH1 DYNC1H1	6.85e-05	3	167	2	23589491
Pubmed	Distribution and functional properties of human KCNH8 (Elk1) potassium channels.	KCNH8 KCNH3	6.85e-05	3	167	2	12890647
Pubmed	Growth hormone stimulates the tyrosine phosphorylation and association of p125 focal adhesion kinase (FAK) with JAK2. Fak is not required for stat-mediated transcription.	PTK2 TNS1	6.85e-05	3	167	2	9553131
Pubmed	Extracellular vesicle-derived TP53BP1, CD34, and PBX1 from human peripheral blood serve as potential biomarkers for the assessment and prediction of vascular aging.	PBX1 TP53BP1	6.85e-05	3	167	2	38173016
Pubmed	Bardet-Biedl syndrome proteins control the cilia length through regulation of actin polymerization.	MKKS TTC8	6.85e-05	3	167	2	23716571
Pubmed	PRKX, TTBK2 and RSK4 expression causes Sunitinib resistance in kidney carcinoma- and melanoma-cell lines.	TTBK2 RPS6KA6	6.85e-05	3	167	2	22020623
Pubmed	BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexes.	PRKDC TP53BP1	6.85e-05	3	167	2	30352856
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH2 MYH3 MYH6 MYLK ACACB SPTBN1 ASH1L OR5AR1 RYR2 MDN1 GSTK1 SYNE2 NCAPD2 ANKRD30A ACIN1 PRKDC PLEC MCF2L PLCH1	6.90e-05	1442	167	19	35575683
Pubmed	Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex.	MED23 MED7 MED12	7.04e-05	17	167	3	10235266
Pubmed	USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c.	ACACB RFC1 ACIN1 PLEC DYNC1H1	7.60e-05	90	167	5	35654790
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	PPP4R1 NCAPD3 ATR SIN3A FHIP2A PTK2 POLR3A TGM2 ARHGEF1 AP4B1 PLCH1 ZNF574	7.76e-05	650	167	12	38777146
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	ACACB ATR HDAC3 WIZ SASH3 ARHGEF1 ACIN1 PLEC DYNC1H1	8.11e-05	370	167	9	22922362
Interaction	BRCA1 interactions	NCOA2 NCAPD3 ZNF280D ATR SPTBN1 CEP57L1 ZYG11B RFC1 SKP2 TRIP11 CCNE1 TGM2 NDC1 NF1 MDN1 WIZ BABAM1 ZNF827 PRKDC PLEC TNKS2 PCBP2 MED12 DYNC1H1 TP53BP1 KNL1	1.03e-05	1249	165	26	int:BRCA1
Interaction	ITGB3 interactions	SPTBN1 PTK2 TGM2 MDN1 PLA2G4A PRKDC PLEC DYNC1H1 TP53BP1	1.14e-05	170	165	9	int:ITGB3
Interaction	DISC1 interactions	PPP4R1 SGSH SPTBN1 CEP57L1 SKP2 TRIP11 KMO TGM2 PCNX4 LRP4 ATG9A AP4B1 TNKS2 DYNC1H1	1.24e-05	429	165	14	int:DISC1
Interaction	NR3C1 interactions	NCOA2 MYH2 NCAPD3 MXRA5 WDR64 ACACB URB2 RFC1 HM13 TRIP11 RYR2 TTBK2 RAB3GAP1 NF1 MDN1 PRELP SYNE2 PRKDC MCF2L PBX1 PCYOX1 KNL1	1.55e-05	974	165	22	int:NR3C1
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF131 ZFAT ZNF234 ZNF781 ZNF813 MECOM ZNF275 ZNF829 ZNF276 WIZ ZNF827 ZBTB40 ZNF574 ZNF646 ZNF662	9.02e-05	718	121	15	28
GeneFamily	Myosin heavy chains	MYH2 MYH3 MYH6	1.25e-04	15	121	3	1098
GeneFamily	C2 tensin-type domain containing\|PTEN protein phosphatases\|Phosphoinositide phosphatases	TPTE TNS1	4.38e-04	5	121	2	902
GeneFamily	DNAJ (HSP40) heat shock proteins\|C2 tensin-type domain containing	TPTE TNS1	1.21e-03	8	121	2	837
GeneFamily	Cyclins\|Mediator complex	MED23 MED7 MED12	1.38e-03	33	121	3	1061
Coexpression	OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP	DIS3L2 PCNX3 SPTBN1 POLR3A SASH3 TRAPPC10 ACIN1 PLEC DYNC1H1	3.86e-07	146	165	9	M41190
Coexpression	GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP	URB2 POLR3A FOCAD DGLUCY THADA NDC1 NF1 MDN1 ZBTB40 UVRAG	5.21e-07	197	165	10	M7403
Coexpression	NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN	NCOA2 SPTBN1 KMO STK10 TTBK2 NF1 ANAPC1 RAPGEF3 ACIN1 VGLL4 DHX29	2.80e-06	294	165	11	M41112
Coexpression	SENESE_HDAC3_TARGETS_UP	SFRP1 SPTBN1 ASH1L SKP2 STK10 NF1 PCNX4 KCNMA1 NAV3 TRAPPC10 ATP13A3 TNKS2 STX16	1.63e-05	495	165	13	M8451
Coexpression	GSE40493_BCL6_KO_VS_WT_TREG_UP	ZYG11B KCTD21 URB2 SSH3 TNKS2 DYNC1H1 GOLGA4 SOS2	1.72e-05	177	165	8	M9401
Coexpression	MITSIADES_RESPONSE_TO_APLIDIN_DN	SPTBN1 SKP2 CCNE1 NDC1 MDN1 NCAPD2 ATP13A3 PRKDC PLEC	3.11e-05	250	165	9	M11318
Coexpression	GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP	ACACB SPTBN1 LILRA6 NF1 GSTK1 MCF2L UVRAG HECA	3.70e-05	197	165	8	M5295
Coexpression	SMID_BREAST_CANCER_BASAL_DN	ACACB SGSH NAIP KMO INPP4B DGLUCY NF1 RAPGEF3 SSH3 SLIT3 KCNMA1 NAV3 MCF2L PBX1 PCBP2	3.82e-05	699	165	15	M4960
Coexpression	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP	PPP4R1 ZNF234 ZYG11B URB2 SKP2 PTK2 TTC8 PCYOX1	3.98e-05	199	165	8	M4274
Coexpression	LIAO_METASTASIS	ZNF234 GCNT3 PCNX3 SGSH SPTBN1 MECOM URB2 PTK2 CCNE1 ZNF827 ARHGEF1 NAV3 VGLL4	4.01e-05	540	165	13	M13809
Coexpression	GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN	ZNF131 ZNF280D SPTBN1 ICE1 STK10 MDN1 ARHGEF1 AP4B1	4.12e-05	200	165	8	M8278
Coexpression	GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN	SPTBN1 ZYG11B RYR2 URB1 TXLNB GSTK1 FRMD6 RPS6KA6	4.12e-05	200	165	8	M8465
Coexpression	WONG_ADULT_TISSUE_STEM_MODULE	MYH3 LILRB3 SFRP1 MYLK ASH1L ZNF275 RYR2 STK10 TGM2 GSTK1 FRMD6 KCNMA1 LRP4 PBX1 TP53BP1	5.42e-05	721	165	15	M1999
Coexpression	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	NCOA2 ZNF131 MECOM SKP2 WIZ KCNMA1 NAV3 PBX1	9.13e-05	224	165	8	M2500
Coexpression	ZHANG_BREAST_CANCER_PROGENITORS_UP	NCAPD3 ATR RFC1 ERI2 SKP2 ANAPC1 NCAPD2 RPS6KA6 TRAPPC10 TP53BP1 PCYOX1	1.02e-04	434	165	11	M15150
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANGPT1 MYLK SHC3 TGM2 FRMD6 SLIT3 KCNMA1 PLA2G4A PBX1	4.65e-08	191	167	9	806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCell	IPF-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	MXRA5 ANGPT1 MYLK RYR2 FRMD6 PRELP SLIT3 NAV3 PBX1	5.81e-08	196	167	9	7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	ANGPT1 MYLK INPP4B RYR2 FRMD6 PRELP SLIT3 NAV3 PBX1	6.34e-08	198	167	9	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Tnaive/CM_CD8\|GI_small-bowel / Manually curated celltypes from each tissue	MYH3 ACACB URB2 SKP2 PTK2 ZNF276 NDC1 RPS6KA6	2.44e-07	168	167	8	c51244b4bdbfd961e2725306aa9cb25dd66d58bd
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANGPT1 MYLK SHC3 TGM2 FRMD6 KCNMA1 PLA2G4A PBX1	5.99e-07	189	167	8	c734e5693808a0333139e87bd5be2597a9252afe
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANGPT1 MYLK SHC3 TGM2 FRMD6 KCNMA1 PLA2G4A PBX1	6.48e-07	191	167	8	c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANGPT1 MYLK SHC3 TGM2 FRMD6 KCNMA1 PLA2G4A PBX1	6.48e-07	191	167	8	cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	ANGPT1 MYLK INPP4B RYR2 TGM2 SLIT3 NAV3 PBX1	7.58e-07	195	167	8	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	IPF-Stromal-Myofibroblast\|IPF / Disease state, Lineage and Cell class	MXRA5 ANGPT1 MYLK RYR2 FRMD6 PRELP SLIT3 NAV3	7.88e-07	196	167	8	2d0a48e49b3b37bb66e33e74c52915911e1f8a74
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	MXRA5 ANGPT1 MYLK RYR2 FRMD6 SLIT3 NAV3 PBX1	8.18e-07	197	167	8	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANGPT1 MYLK INPP4B RYR2 TGM2 PRELP SLIT3 NAV3	9.17e-07	200	167	8	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CCDC168 ERI2 AKR1C2 TTC8 FAM47E HECA MED12	2.09e-06	156	167	7	c11ca6b1b5029c15aab91273cece70a487287839
ToppCell	droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACACB CYP27A1 MECOM FBXL21P NDC1 LRP4 MYO16	3.29e-06	167	167	7	3c06894fc6177f3c204094719904da42f08b9af8
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANGPT1 MYLK INPP4B RYR2 SLIT3 PBX1 TNS1	4.15e-06	173	167	7	5416b092321c7d9b63f0418c60f2402a138355bf
ToppCell	P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANGPT1 MYLK CYP27A1 TGM2 PRELP SLIT3 TNS1	4.31e-06	174	167	7	3c47d069bd836599a8d40eae485c23d4d3487517
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|390C / Donor, Lineage, Cell class and subclass (all cells)	MXRA5 APCDD1 PCDHB9 CCDC168 ERI2 RYR2 PRELP	4.65e-06	176	167	7	852d3da0907fe87c0ef23d75a63ce07619cf0c54
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	MXRA5 APCDD1 PCDHB9 CCDC168 ERI2 RYR2 PRELP	4.65e-06	176	167	7	d2df1e435996c51213e88270af9f928e9e09a6f5
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANGPT1 RYR2 SULT1E1 TTC8 SLIT3 NAV3 MYO16	5.39e-06	180	167	7	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	ANGPT1 MYLK INPP4B RYR2 SLIT3 KCNMA1 TNS1	5.39e-06	180	167	7	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANGPT1 MYLK CYP27A1 PRELP LRP4 PBX1 TNS1	6.23e-06	184	167	7	924400f47e6b2cdf7b0d538df75857935cf0209b
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANGPT1 MYLK CYP27A1 TGM2 PRELP PBX1 TNS1	6.45e-06	185	167	7	46460e74cc613df9043f5404e7342aa13cc34873
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNH8 MYLK CCDC168 ZNF827 BMP8A ST8SIA4 PLCH1	6.45e-06	185	167	7	5a0340c25196453f19e424d346efbf66d2c53ac3
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANGPT1 MYLK SHC3 TGM2 FRMD6 PLA2G4A PBX1	7.68e-06	190	167	7	2e592323085ba9c019d678ac2a784462ab470ed9
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANGPT1 MYLK SHC3 TGM2 FRMD6 PLA2G4A PBX1	7.68e-06	190	167	7	445952b70abffadb6ccc1ed4bbf61a88b06b73b3
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANGPT1 RYR2 PRELP SLIT3 KCNMA1 LRP4 MYO16	7.95e-06	191	167	7	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	ASK454-Mesenchymal\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	MXRA5 ANGPT1 MYLK APCDD1 RYR2 PRELP SLIT3	7.95e-06	191	167	7	e30ae7a12439f8a79820b13f03e822c1223fd0cb
ToppCell	ASK454-Mesenchymal-Fibroblast\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	MXRA5 ANGPT1 MYLK APCDD1 RYR2 PRELP SLIT3	7.95e-06	191	167	7	1726add3f392a061536b7aff72ba84303f4a0b1f
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANGPT1 MYLK INPP4B RYR2 SLIT3 NAV3 PBX1	8.22e-06	192	167	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNH8 MYLK LINGO2 PITPNM1 BMP8A ST8SIA4 MYO16	8.22e-06	192	167	7	25460ca9ebd3d49f666394cf99ab77a5e8f77250
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANGPT1 MYLK RYR2 SLIT3 NAV3 PBX1 TNS1	8.80e-06	194	167	7	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFRP1 CYP27A1 SULT1E1 FRMD6 PRELP SLIT3 PBX1	8.80e-06	194	167	7	da926441053b499cb5107ccb116fb1b3844d82b7
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SFRP1 ANGPT1 SHC3 FRMD6 PRELP SLIT3 PLA2G4A	8.80e-06	194	167	7	240d122dcb9dd1ab2867503ad85869853adcacae
ToppCell	RA\|World / Chamber and Cluster_Paper	MYH6 MECOM AKR1C2 TGM2 PRELP SLIT3 ATP13A3	8.80e-06	194	167	7	08f0afbb68a63150fbe107a5337299081c3f69e4
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANGPT1 MYLK RYR2 SULT1E1 TGM2 SLIT3 NAV3	8.80e-06	194	167	7	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SFRP1 ANGPT1 SHC3 FRMD6 PRELP SLIT3 PLA2G4A	8.80e-06	194	167	7	ae7df037592f1c20c9d32be15fe6fc3c562ebeb1
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFRP1 CYP27A1 SULT1E1 FRMD6 PRELP SLIT3 PBX1	8.80e-06	194	167	7	54a7f693966b5c02f6b248950ddb5fa32af3ae67
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFRP1 CYP27A1 SULT1E1 FRMD6 PRELP SLIT3 PBX1	8.80e-06	194	167	7	f34b3bbdebf56f66ff499e390e5515a4a4093f90
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANGPT1 SHC3 INPP4B FRMD6 PRELP SLIT3 PLA2G4A	9.09e-06	195	167	7	d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	ANGPT1 MYLK INPP4B RYR2 SLIT3 NAV3 PBX1	9.09e-06	195	167	7	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SFRP1 ANGPT1 SHC3 FRMD6 PRELP SLIT3 PLA2G4A	9.09e-06	195	167	7	44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SFRP1 ANGPT1 SHC3 FRMD6 PRELP SLIT3 PLA2G4A	9.40e-06	196	167	7	ba869f7a86f37fd6d84d6ad69baca0e0faaf5887
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SFRP1 ANGPT1 SHC3 FRMD6 PRELP SLIT3 PLA2G4A	9.40e-06	196	167	7	30ad56d49000e4ddce73b4443b3994564bd1e2d6
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANGPT1 MYLK RYR2 PRELP SLIT3 NAV3 PBX1	9.40e-06	196	167	7	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	COPD-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	ANGPT1 MYLK RYR2 PRELP SLIT3 NAV3 PBX1	9.72e-06	197	167	7	d51f484b4e01ac64233950d0b97fa88825ea1dbb
ToppCell	distal-mesenchymal-Vascular_Smooth_Muscle-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ANGPT1 MYLK PTK2 INPP4B RYR2 PRELP SLIT3	9.72e-06	197	167	7	da653dc7d216e202f390e5ab0245f243e3ed213b
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	ANGPT1 MYLK RYR2 FRMD6 SLIT3 NAV3 PBX1	9.72e-06	197	167	7	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANGPT1 MYLK RYR2 PRELP SLIT3 NAV3 PBX1	1.00e-05	198	167	7	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANGPT1 MYLK RYR2 PRELP SLIT3 NAV3 PBX1	1.00e-05	198	167	7	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	IPF-Stromal\|IPF / Disease state, Lineage and Cell class	MXRA5 MYLK RYR2 FRMD6 PRELP SLIT3 PBX1	1.00e-05	198	167	7	ece914c32c9b123b779aa9624b92e6230763a20e
ToppCell	Transverse-Macrophage-LYVE1_Macrophage\|Transverse / Region, Cell class and subclass	LILRB3 CYP27A1 LILRA6 KL VENTX KCNMA1 PLA2G4A	1.04e-05	199	167	7	facf79c256db5ae57bdb613e86ec90616a6f67ca
ToppCell	Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage\|Transverse / shred on region, Cell_type, and subtype	LILRB3 CYP27A1 LILRA6 KL VENTX KCNMA1 PLA2G4A	1.04e-05	199	167	7	dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MXRA5 ANGPT1 RYR2 FRMD6 SLIT3 ATP13A3 MYO16	1.04e-05	199	167	7	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	343B-Fibroblasts-Fibroblast-G\|343B / Donor, Lineage, Cell class and subclass (all cells)	MXRA5 ANGPT1 MYLK RYR2 TGM2 PRELP SLIT3	1.04e-05	199	167	7	f4b6c095cbe7a38b310adc49be4069e4d56e6a66
ToppCell	343B-Fibroblasts-Fibroblast-G-\|343B / Donor, Lineage, Cell class and subclass (all cells)	MXRA5 ANGPT1 MYLK RYR2 TGM2 PRELP SLIT3	1.04e-05	199	167	7	9c6d1c328bfbb6547f4c7bb2a784576a56bd72af
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	SFRP1 MYLK RYR2 FRMD6 PRELP KCNMA1 LRP4	1.07e-05	200	167	7	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LILRB3 LILRA6 GPR141 IDO2 CATSPER4 ROS1	1.74e-05	144	167	6	8bd042f12186f36bc5aabf6a0232270a448f4b58
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MKKS ANGPT1 CASR ZYG11B ZNF275 ZNF574	2.20e-05	150	167	6	c2c51a3230c978e2fdb1b3ae14193d4014431b25
ToppCell	E16.5-samps-Myeloid\|E16.5-samps / Age Group, Lineage, Cell class and subclass	LILRB3 CYP27A1 LILRA6 TLR7 STK10 SASH3	2.74e-05	156	167	6	c7c73cef5700b0ae75280e62c94728434c712537
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCAPD3 INPP4B ARHGEF1 SYNE2 SLIT3 MCF2L	3.27e-05	161	167	6	5fba13f0aa5002f7eefe219e2c6a07e163f1a50d
ToppCell	LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MTERF3 CYP27A1 URB2 AKR1C2 LRP4 SERPIND1	3.51e-05	163	167	6	6b11a3ada8725670d0489f404c8c2175ad3904e9
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANGPT1 MYLK INPP4B RYR2 SLIT3 TNS1	3.75e-05	165	167	6	8a82e20c9b1156bb4bbc16f7785abb04458d671b
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	PCDHB9 CHRNB2 CCNE1 KCNMA1 PLCH1 MYO16	4.02e-05	167	167	6	9efb9511a211d0824bb97f82c1a5860c43d2138f
ToppCell	Cerebellum-Neuronal-Inhibitory\|Cerebellum / BrainAtlas - Mouse McCarroll V32	PCDHB9 CHRNB2 CCNE1 KCNMA1 PLCH1 MYO16	4.02e-05	167	167	6	904c613aac3f9919a432b110bb1dcc832b5aec0a
ToppCell	droplet-Marrow-nan-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFAT SGSH CYP27A1 TRIP11 MCF2L PHLPP2	4.29e-05	169	167	6	5f5bec13208f4c3b6eacbba180c8a6402743b76e
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYLK CCDC168 FRMD6 ROS1 BMP8A PLCH1	5.38e-05	176	167	6	40993c41c1017b53039a337174fc56632b278609
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYLK LINGO2 CCDC168 ROS1 BMP8A PLCH1	5.55e-05	177	167	6	f902600c639087664316b3cf30cab243bc3d1c5c
ToppCell	(9)_Platelet\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ANGPT1 MYLK RYR2 PLCH1 PBX1 TNS1	5.55e-05	177	167	6	0830944c43de300815831a9e2b2fce40965e7d12
ToppCell	356C-Fibroblasts-Fibroblast-G\|356C / Donor, Lineage, Cell class and subclass (all cells)	MXRA5 ANGPT1 MYLK RYR2 TGM2 PRELP	5.55e-05	177	167	6	8220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell	(9)_Platelet\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ANGPT1 MYLK RYR2 PLCH1 PBX1 TNS1	5.55e-05	177	167	6	e63d01c7fce4fa1256212fa7e95f74281edb3a01
ToppCell	356C-Fibroblasts-Fibroblast-G-\|356C / Donor, Lineage, Cell class and subclass (all cells)	MXRA5 ANGPT1 MYLK RYR2 TGM2 PRELP	5.55e-05	177	167	6	7617270f49cd6b7ba66db72d20560cee985012b2
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SFRP1 ANGPT1 MECOM SHC3 KL MYO16	5.55e-05	177	167	6	c9e8149639551a4c8daa90fcb2b895fdcff2e2ba
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNH8 MYLK CCDC168 BMP8A ST8SIA4 PLCH1	6.09e-05	180	167	6	a407376209d80177bf7fc4200219030c83cb5f14
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANGPT1 SULT1E1 TTC8 SLIT3 NAV3 MYO16	6.09e-05	180	167	6	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANGPT1 SULT1E1 TTC8 TXLNB SLIT3 MYO16	6.28e-05	181	167	6	9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANGPT1 CYP27A1 PRELP LRP4 PBX1 TNS1	6.28e-05	181	167	6	091e7975badd1ffa463a8ec87908be20781ecfd6
ToppCell	facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANGPT1 MYLK PCDHB9 PRELP SLIT3 TNS1	6.48e-05	182	167	6	c557de6ccd327c46e0a5423cd9936d78e0abae5f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANGPT1 MYLK PCDHB9 PRELP SLIT3 TNS1	6.48e-05	182	167	6	dbe4b2557cf19e0682ed446f8397d3a1153642f0
ToppCell	P28-Mesenchymal\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANGPT1 MYLK PRELP LRP4 PBX1 TNS1	6.48e-05	182	167	6	69f9d44694fe4f55a971ae0ac5dc3e7448ee78f3
ToppCell	Pericytes-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	ANGPT1 MYLK CCDC168 INPP4B RYR2 PRELP	6.68e-05	183	167	6	d04deef7cd4e1738227a6593b84874ce0168c773
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR2 DNAH1 NAV3 ROS1 PLCH1 MYO16	6.88e-05	184	167	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNH8 LINGO2 BMP8A ST8SIA4 PLCH1 MYO16	6.88e-05	184	167	6	658f2e522055e88c92bc482a845c40f8f5f1a8e3
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR2 DNAH1 NAV3 ROS1 PLCH1 MYO16	6.88e-05	184	167	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR2 DNAH1 NAV3 ROS1 PLCH1 MYO16	6.88e-05	184	167	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CEP57L1 SKP2 CCNE1 NDC1 NCAPD2 KNL1	7.09e-05	185	167	6	47c69500877b851c0c9744f5e1ef2ee0bff99168
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNH8 MYLK LINGO2 ST8SIA4 PLCH1 MYO16	7.09e-05	185	167	6	10da5c2a92bfb3248d3f6f94a0933996326cf590
ToppCell	droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFRP1 ACACB MECOM CASR RYR2 SYNE2	7.30e-05	186	167	6	8eafd4bea692f7ef33de27dd53f9d1fe67deaad8
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	ASH1L URB1 NDC1 ZBTB40 PRKDC ST8SIA4	7.30e-05	186	167	6	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANGPT1 MYLK CYP27A1 TGM2 PRELP TNS1	7.30e-05	186	167	6	88e6246172d816806a498a5c1f38e699f2f5d7c2
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SFRP1 INPP4B SLIT3 PLA2G4A PBX1 TNS1	7.52e-05	187	167	6	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	ANGPT1 MYLK RYR2 SLIT3 NAV3 PBX1	7.52e-05	187	167	6	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	PTK2 INPP4B TGM2 PRELP SLIT3 BMP8A	7.52e-05	187	167	6	1aebf6fab40b96f2f5feb77a302bb805838fccf3
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	ANGPT1 MYLK RYR2 FRMD6 SLIT3 NAV3	7.52e-05	187	167	6	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	IPF-Stromal-SMC\|World / Disease state, Lineage and Cell class	ANGPT1 MYLK RYR2 PRELP SLIT3 PBX1	7.75e-05	188	167	6	b66264e8f8d536ed2beec31e6746c687718f239b
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ASH1L NF1 SYNE2 ATP13A3 DYNC1H1 TP53BP1	7.75e-05	188	167	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	droplet-Lung-immune-endo-depleted\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK PRELP SLIT3 LRP4 PBX1 TNS1	7.98e-05	189	167	6	c3fb363bb0156ffb3367c200f548faebda64ab4a
ToppCell	droplet-Lung-immune-endo-depleted-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK PRELP SLIT3 LRP4 PBX1 TNS1	7.98e-05	189	167	6	2a2953f6b1b7d070d739dcaf7285fce6e097d9e4
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	NCOA2 ACACB MECOM CASR PTK2 PBX1	7.98e-05	189	167	6	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	droplet-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYLK PRELP SLIT3 LRP4 PBX1 TNS1	7.98e-05	189	167	6	5a636e952da9b1fd26aa17f7b129054f2da322b5
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANGPT1 MYLK PRELP SLIT3 LRP4 TNS1	7.98e-05	189	167	6	e76dc36a01d8ad7590b3acc4c46abfcb76857448
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RYR2 FRMD6 PRELP SLIT3 KCNMA1 LRP4	7.98e-05	189	167	6	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
Drug	alpha-bromo-4-chlorophenylacetic acid	LILRB3 LILRA6 DYNC1H1	3.81e-07	3	166	3	CID010490868
Drug	l-945	LILRB3 LILRA6 DYNC1H1	3.81e-07	3	166	3	CID000097919
Drug	cupric acetate monohydrate	LILRB3 LILRA6 DYNC1H1	3.77e-06	5	166	3	CID000165397
Drug	DBTA	LILRB3 LILRA6 DYNC1H1	7.49e-06	6	166	3	CID000149053
Drug	16, 16-dimethylprostaglandin E2 methyl acetate solution; Down 200; 10uM; PC3; HT_HG-U133A	PTK2 RAB3GAP1 NF1 ACIN1 PRKDC PLEC PCBP2 TNS1 SERPIND1	1.43e-05	196	166	9	6562_DN
Drug	Midecamycin [35457-80-8]; Down 200; 5uM; PC3; HT_HG-U133A	ACACB SGSH SPTBN1 SKP2 WIZ SSH3 PLCH1 TNS1 SOS2	1.43e-05	196	166	9	6745_DN
Drug	Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SGSH ASH1L MECOM RYR2 TGM2 NF1 ZBTB40 PLEC ZNF574	1.61e-05	199	166	9	7339_DN
Drug	geldanamycin	NCOA2 ANGPT1 SPTBN1 PTK2 NF1 ATP13A3 TNKS2 MED7 PCBP2 TP53BP1 KNL1 SOS2	1.88e-05	371	166	12	ctd:C001277
Drug	DITPA	MYH6 ANGPT1 RYR2 MED12	2.58e-05	24	166	4	CID000160565
Drug	Daunorubicin	NCOA2 MYH6 NRAP ANGPT1 AKR1C2 INPP4B RYR2 CCNE1 SLIT3	3.08e-05	216	166	9	ctd:D003630
Drug	2-bromopropionate	LILRB3 LILRA6 DYNC1H1	3.10e-05	9	166	3	CID000011729
Disease	testosterone measurement	MYH2 ZNF280D UGT2A2 MECOM LINGO2 SIN3A ZNF275 AKR1C2 URB1 THADA VENTX NF1 ANAPC1 SYNE2 FAM47E BMP8A TNKS2 MED23 MED12 MYO16 KNL1 SOS2	1.82e-06	1275	161	22	EFO_0004908
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH2 MYH3 MYH6	1.86e-05	10	161	3	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH2 MYH3 MYH6	1.86e-05	10	161	3	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH2 MYH3 MYH6	1.86e-05	10	161	3	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH2 MYH3 MYH6	1.86e-05	10	161	3	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH2 MYH3 MYH6	1.86e-05	10	161	3	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH2 MYH3 MYH6	1.86e-05	10	161	3	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH2 MYH3 MYH6	1.86e-05	10	161	3	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH2 MYH3 MYH6	1.86e-05	10	161	3	DOID:0080326 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH2 MYH3 MYH6	3.38e-05	12	161	3	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH2 MYH3 MYH6	3.38e-05	12	161	3	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH2 MYH3 MYH6	4.38e-05	13	161	3	DOID:397 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH2 MYH3 MYH6	6.91e-05	15	161	3	DOID:0050646 (implicated_via_orthology)
Disease	primary autosomal recessive microcephaly (is_implicated_in)	NCAPD3 NCAPD2 KNL1	8.47e-05	16	161	3	DOID:0070296 (is_implicated_in)
Disease	Malignant neoplasm of breast	NCOA2 TPTE SFRP1 MECOM DTX3L INPP4B METTL6 CCNE1 TGM2 NF1 SYNE2 ANKRD30A PLA2G4A TNS1 MED12 TP53BP1 ZNF646	8.54e-05	1074	161	17	C0006142
Disease	amino acid measurement	ACACB LINGO2 RYR2 OR51B5 SLIT3 KCNMA1 NAV3 ZBTB40 PLA2G4A PRKDC AP4B1 TNKS2 MYO16	9.46e-05	678	161	13	EFO_0005134
Disease	ovarian neoplasm	ATR MECOM SKP2 CCNE1 BABAM1 TP53BP1	9.70e-05	134	161	6	C0919267
Disease	Malignant neoplasm of ovary	ATR MECOM SKP2 CCNE1 BABAM1 TP53BP1	1.10e-04	137	161	6	C1140680
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	ERN1 INPP4B TGM2 SYNE2 KCNMA1 NAV3	1.67e-04	148	161	6	C0279702
Disease	Muscular Atrophy, Spinal, Type II	NAIP DYNC1H1	1.76e-04	4	161	2	C0393538
Disease	Muscular atrophy, spinal, infantile chronic form	NAIP DYNC1H1	1.76e-04	4	161	2	C2931358
Disease	Juvenile Spinal Muscular Atrophy	NAIP DYNC1H1	1.76e-04	4	161	2	C0152109
Disease	HMN (Hereditary Motor Neuropathy) Proximal Type I	NAIP DYNC1H1	1.76e-04	4	161	2	C0043116
Disease	cardiac troponin T measurement	NCOA2 MECOM CASR LINGO2 NF1 TXLNB UVRAG	2.09e-04	219	161	7	EFO_0005043
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	TDRD15 ZNF280D ACACB DNAH1 SYNE2 TNKS2 TP53BP1	2.40e-04	224	161	7	EFO_0004530, EFO_0008317
Disease	Weight Gain	SPTBN1 AKR1C2 NDC1 KCNMA1 PCYOX1	2.47e-04	102	161	5	C0043094
Disease	monocyte count	LILRB3 ANGPT1 SPTBN1 ASH1L LILRA6 MECOM ZYG11B MEI1 SHC3 CHRNB2 THADA ZNF276 NF1 PRKDC ST8SIA4 PBX1 SERPIND1 MYO16	3.31e-04	1320	161	18	EFO_0005091
Disease	systemic mastocytosis	OR51B5 OR51Q1 NAV3	3.36e-04	25	161	3	MONDO_0016586
Disease	Glioblastoma Multiforme	ERN1 PTK2 TGM2 NF1 TP53BP1	3.66e-04	111	161	5	C1621958
Disease	leukocyte immunoglobulin-like receptor subfamily B member 3 measurement	LILRB3 LILRA6	4.37e-04	6	161	2	EFO_0802705
Disease	leukocyte immunoglobulin-like receptor subfamily A member 6 measurement	LILRB3 LILRA6	4.37e-04	6	161	2	EFO_0801767
Disease	alkaline phosphatase measurement	NCOA2 TDRD15 ACACB ERN1 SPTBN1 FHIP2A NF1 ZNF827 ZBTB40 FAM47E BMP8A TNKS2 TP53BP1 PCYOX1 PHLPP2	4.66e-04	1015	161	15	EFO_0004533
Disease	intraocular pressure measurement	MXRA5 ANGPT1 ZNF280D SPTBN1 MECOM THADA ANAPC1 LRP4 TNS1 SOS2	5.09e-04	509	161	10	EFO_0004695
Disease	quinolinate measurement	KMO IDO2	6.10e-04	7	161	2	EFO_0800175
Disease	cardiomyopathy (implicated_via_orthology)	MYH2 MYH3 MYH6 CASR	6.24e-04	71	161	4	DOID:0050700 (implicated_via_orthology)
Disease	Sarcomatoid Renal Cell Carcinoma	INPP4B TGM2 SYNE2 KCNMA1 NAV3	7.01e-04	128	161	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	INPP4B TGM2 SYNE2 KCNMA1 NAV3	7.01e-04	128	161	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	INPP4B TGM2 SYNE2 KCNMA1 NAV3	7.01e-04	128	161	5	C1266044
Disease	Papillary Renal Cell Carcinoma	INPP4B TGM2 SYNE2 KCNMA1 NAV3	7.01e-04	128	161	5	C1306837
Disease	Renal Cell Carcinoma	INPP4B TGM2 SYNE2 KCNMA1 NAV3	7.01e-04	128	161	5	C0007134
Disease	Large cell carcinoma of lung	ATR RPS6KA6 ROS1	7.04e-04	32	161	3	C0345958
Disease	Breast Carcinoma	NCOA2 SFRP1 MECOM INPP4B METTL6 CCNE1 TGM2 PLA2G4A MED12 TP53BP1	7.79e-04	538	161	10	C0678222
Disease	Glioblastoma	PTK2 TGM2 NF1 TP53BP1	9.33e-04	79	161	4	C0017636
Disease	Obesity	MKKS ACACB APCDD1 TTC8 RAPGEF3 KCNMA1	9.43e-04	205	161	6	C0028754
Disease	free androgen index	MYH2 SIN3A ZNF275 AKR1C2 URB1 THADA FAM47E TNKS2	1.08e-03	374	161	8	EFO_0007005
Disease	Giant Cell Glioblastoma	PTK2 TGM2 NF1 TP53BP1	1.17e-03	84	161	4	C0334588
Disease	lean body mass	PPP4R1 ZFAT DIS3L2 LINGO2 KCNMA1 ZBTB40 VGLL4 PLEC	1.18e-03	379	161	8	EFO_0004995
Disease	4-vinylphenol sulfate measurement	ANGPT1 SOS2	1.29e-03	10	161	2	EFO_0021149
Disease	endometrial hyperplasia (is_marker_for)	SKP2 PTK2	1.29e-03	10	161	2	DOID:0080365 (is_marker_for)
Disease	Glioma	MYLK ATR NF1 ROS1	1.34e-03	87	161	4	C0017638
Disease	triglycerides in large LDL measurement	TDRD15 SYNE2 TP53BP1	1.68e-03	43	161	3	EFO_0022319
Disease	pulmonary function measurement, forced expiratory volume, smoking behaviour measurement	MECOM TNS1	1.88e-03	12	161	2	EFO_0003892, EFO_0004314, EFO_0005671
Disease	interleukin 17 measurement	ZNF276 NAV3 ANKRD30A	1.91e-03	45	161	3	EFO_0008174
Disease	Hypercalcemia	CASR KL	2.22e-03	13	161	2	C0020437
Disease	Milk-Alkali Syndrome	CASR KL	2.22e-03	13	161	2	C0026141
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	TDRD15 ACACB SYNE2 TNKS2 TP53BP1	2.22e-03	166	161	5	EFO_0004530, EFO_0004611
Disease	myopathy (implicated_via_orthology)	MYH2 MYH3 MYH6	2.30e-03	48	161	3	DOID:423 (implicated_via_orthology)
Disease	Mammary Carcinoma, Human	NCOA2 SFRP1 MECOM METTL6 CCNE1 TGM2 PLA2G4A MED12 TP53BP1	2.46e-03	525	161	9	C4704874
Disease	Mammary Neoplasms, Human	NCOA2 SFRP1 MECOM METTL6 CCNE1 TGM2 PLA2G4A MED12 TP53BP1	2.46e-03	525	161	9	C1257931
Disease	Mammary Neoplasms	NCOA2 SFRP1 MECOM METTL6 CCNE1 TGM2 PLA2G4A MED12 TP53BP1	2.52e-03	527	161	9	C1458155
Disease	Metabolic Bone Disorder	CYP27A1 KCNMA1	2.58e-03	14	161	2	C0005944
Disease	Bardet-Biedl syndrome (is_implicated_in)	MKKS TTC8	2.58e-03	14	161	2	DOID:1935 (is_implicated_in)
Disease	QRS-T angle	ANGPT1 SPTBN1 RYR2 BMP8A	2.75e-03	106	161	4	EFO_0020097
Disease	response to antidepressant	ZFAT MROH5 NT5C3B LINGO2 OR51B5	2.86e-03	176	161	5	GO_0036276
Disease	cortical surface area measurement	NCOA2 NCAPD3 SFRP1 ANGPT1 PCNX3 APCDD1 SPTBN1 MECOM FOCAD THADA NAV3 MED23 PCBP2 TNS1 MYO16 SOS2	2.89e-03	1345	161	16	EFO_0010736
Disease	Osteopenia	CYP27A1 KCNMA1	2.97e-03	15	161	2	C0029453
Disease	waist-hip ratio	ZFAT DIS3L2 ZNF280D APCDD1 MECOM LINGO2 TRIP11 CCNE1 DGLUCY THADA RAPGEF3 SYNE2 NAV3 PBX1 KNL1	3.00e-03	1226	161	15	EFO_0004343
Disease	mean corpuscular hemoglobin concentration	ZNF131 MYH2 ZFAT ANGPT1 ATR MECOM URB2 RFC1 SKP2 FOCAD TTBK2 PRKDC FAM47E MYO16	3.02e-03	1105	161	14	EFO_0004528
Disease	susceptibility to common cold measurement	ANGPT1 DGLUCY MYO16	3.23e-03	54	161	3	EFO_0008417
Disease	Intellectual Disability	ASH1L SIN3A FHIP2A NF1 ZBTB40 ACIN1 MED23 DYNC1H1	3.27e-03	447	161	8	C3714756
Disease	lung small cell carcinoma (is_marker_for)	SKP2 PTK2	3.38e-03	16	161	2	DOID:5409 (is_marker_for)
Disease	response to methotrexate	AKR1C2 INPP4B	3.38e-03	16	161	2	GO_0031427
Disease	triglycerides in LDL measurement	TDRD15 SYNE2 TP53BP1	3.58e-03	56	161	3	EFO_0022320
Disease	Bardet-Biedl syndrome 1 (disorder)	MKKS TTC8	3.81e-03	17	161	2	C2936862
Disease	sphingomyelin 14:0 measurement	THADA SYNE2	3.81e-03	17	161	2	EFO_0010390
Disease	triglycerides in IDL measurement	TDRD15 TNKS2 TP53BP1	3.95e-03	58	161	3	EFO_0022149
Disease	forced expiratory volume	ZFAT DIS3L2 MECOM TRIP11 CHRNB2 RYR2 ARHGEF1 KCNMA1 ZBTB40 BMP8A TNS1	4.15e-03	789	161	11	EFO_0004314
Disease	spine bone mineral density	SPTBN1 MECOM KCNMA1 ZBTB40	4.17e-03	119	161	4	EFO_0007701
Disease	caudal middle frontal gyrus volume measurement	ZFAT PCNX4	4.27e-03	18	161	2	EFO_0010290
Disease	Bardet-Biedl syndrome	MKKS TTC8	4.27e-03	18	161	2	cv:C0752166
Disease	disease free survival	ICE1 CCDC168	4.27e-03	18	161	2	EFO_0000409
Disease	sphingomyelin measurement	TDRD15 CASR KCNH3 RAPGEF3 SYNE2 DYNC1H1	4.33e-03	278	161	6	EFO_0010118
Disease	alcohol use disorder (implicated_via_orthology)	ANGPT1 CHRNB2 RYR2 SSH3 KCNMA1	4.42e-03	195	161	5	DOID:1574 (implicated_via_orthology)
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	TDRD15 SYNE2 LRP4 TP53BP1	4.42e-03	121	161	4	EFO_0008595, EFO_0020943
Disease	mean reticulocyte volume	ZFAT ANGPT1 ATR URB2 RFC1 SKP2 OR51B5 THADA ZBTB40 PBX1 MYO16	4.55e-03	799	161	11	EFO_0010701
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	TDRD15 ACACB DNAH1 SYNE2 TP53BP1	4.91e-03	200	161	5	EFO_0004611, EFO_0020945
Disease	renal cell carcinoma (is_marker_for)	SFRP1 ANGPT1 SKP2 CCNE1	5.39e-03	128	161	4	DOID:4450 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
HNVLFSILQCHPKVM	URB2	1371	Q14146
NIHFNLLDPLKNHMK	ZNF280D	246	Q6N043
LMLENLQKHSTPHAA	ACIN1	106	Q9UKV3
PNFHHMEKLLIQISA	NAIP	1126	Q13075
RVNANMSHPLVLGKH	ERI2	511	A8K979
IIRQMKVFHPNIHIV	NT5C3B	166	Q969T7
RNQHMPLESRHLFKF	AADACL2	266	Q6P093
PAHLMALLQHVALQF	ARHGEF1	56	Q92888
PMSNRERNFVLKHHV	ASH1L	2351	Q9NR48
THMYIKQLLRHPAFQ	CATSPER4	81	Q7RTX7
HFQDLVPKLMLHGTV	ATP13A3	841	Q9H7F0
LKHLRHLNFTNNMGE	CASR	461	P41180
QHFLEQHPLLQPKMR	CCNE1	131	P24864
HRTPLMKALQCHQEA	ANKRD30A	106	Q9BXX3
NKPIAHHLLNRMSKL	AP4B1	196	Q9Y6B7
LVSRAMHHLQPLNAK	BTBD11	431	A6QL63
PDFSSQKLQHLEHVM	ANGPT1	76	Q15389
SRTQHAILYMNPHKI	DHX29	831	Q7Z478
MAVAHKIHRAFPEQA	DIS3L2	591	Q8IYB7
EMVHLRKVPNQYTHL	RAB3GAP1	191	Q15042
LMVQKLRHSLLSHQE	GPR141	206	Q7Z602
NKFPVEMTHNHNFRL	SERPIND1	301	P05546
MHLHKEVLQLPLFEA	KCNH3	571	Q9ULD8
VFPDLQSLEKHMLSH	MECOM	271	Q03112
GSPIFLMKLAQHARH	ACACB	486	O00763
HQERLQNHPKRGLFM	ANAPC1	1826	Q9H1A4
HALNCHRMKPALFNV	PBX1	66	P40424
VIHPSLKQFLNMHRI	MKKS	296	Q9NPJ1
IRQEISIMNCLHHPK	MYLK	1506	Q15746
VLKHLVHQIPRLLMN	MDN1	2751	Q9NU22
HPKIRIITQMLQYHN	KCNMA1	516	Q12791
SHPHALDFMNNKIIR	KCTD21	241	Q4G0X4
KAQFHLPLDMAALVH	NRAP	1111	Q86VF7
IPRHKLNTFHVRMED	HECA	356	Q9UBI9
VKLLLMHQANPHLVN	MYO16	271	Q9Y6X6
HLVQPKLLSNMEAQH	GOLGA4	1911	Q13439
LQRMQVHSPHLKDAL	INPP4B	346	O15327
SQGIERLHPMQFDHK	MED7	61	O43513
LIDAHQLQAHVDKMP	IDO2	66	Q6ZQW0
PGVRMALKLHQDHFT	PCNX3	1641	Q9H6A9
PALEHMNQILHILFV	PCNX4	236	Q63HM2
VIHPLNLHMKRFVKD	PCYOX1	91	Q9UHG3
RFGKQVPHIVHLIMS	OR51B5	261	Q9H339
FAKHASPLVHVIMAN	OR51Q1	266	Q8NH59
LNKLMTNLRSTHPHF	MYH2	661	Q9UKX2
KPITQRYFNLLMEHH	NAV3	2036	Q8IVL0
FASFPHMVLSLHQKL	MED23	346	Q9ULK4
RQMLQAPHFKALLSA	MPP4	111	Q96JB8
QLPKMLEEFSLVVHH	KNL1	2221	Q8NG31
LHLKHLNINNMPVYA	LINGO2	206	Q7L985
HLPLVQHVQFIFDLM	MED12	866	Q93074
IFIMHIFKHAQPALL	HM13	306	Q8TCT9
MDPHQRYTAEQILKH	RPS6KA6	666	Q9UK32
HHFVLMKEGEHQLPR	LILRA6	151	Q6PI73
HHFVLMKEGEHQLPR	LILRB3	151	O75022
LKMLNHAPSVQIHDV	HDAC3	366	O15379
LIFVLSAVHPDKMHL	METTL6	156	Q8TCB7
SAVHPDKMHLVLQNI	METTL6	161	Q8TCB7
LSILHNLFVIVPHMK	MEI1	576	Q5TIA1
PDLTKLHQLAMQQSH	PCBP2	241	Q15366
ILKHIPNMHKDQFAL	FRMD6	196	Q96NE9
QGIDSNKLMPRHLDH	DNAH1	211	Q9P2D7
MLCELEHSIKPLFQH	ATR	1856	Q13535
LHHQVEEMLQKISPL	ICE1	71	Q9Y2F5
PNVKMHFNHRLLKCN	KMO	126	O15229
LHNCMAKLLAHPLQR	BABAM1	291	Q9NWV8
KRHPNVHFVLNQESM	DTX3L	476	Q8TDB6
HRDLKPHNILISMPN	ERN1	686	O75460
ILFANKMVNHSLHPT	ATG9A	91	Q7Z3C6
MANDLKLLRHHLQIP	GSTK1	66	Q9Y2Q3
QHKDFAHMPLLKAVL	CYP27A1	376	Q02318
MLQNHHLLANKFDPK	GCNT3	401	O95395
NHAILQSLVHLMKPN	BMP8A	346	Q7Z5Y6
MELLHLVEKNNPGHL	CCDC66	736	A2RUB6
LKHLHNGARITVQMP	APCDD1	56	Q8J025
ELARFKPMQRHLFLH	MCF2L	851	O15068
KPMQRHLFLHEKAVL	MCF2L	856	O15068
LMQLEKKLHSLQPHA	DYNC1H1	4106	Q14204
SFQLLDPHMKFRQLE	KL	376	Q9UEF7
NSSFHPIRVHNLQMK	CEP57L1	436	Q8IYX8
EALLKVIPQHLQHFM	CCDC168	1821	Q8NDH2
EMLLPHTLQNHSVKE	CCDC168	6531	Q8NDH2
TLRMFEHLLQKPNEH	FHIP2A	471	Q5W0V3
PFHNTHAEMIQKLVD	DGLUCY	596	Q7Z3D6
HLNELNIMDPQHRAK	SASH3	291	O75995
MGIFHNEDLKHILQL	RYR2	1831	Q92736
RNTHGLIKAIMHLLQ	FOCAD	96	Q5VW36
GFKHNEIQHMITRIP	MTERF3	306	Q96E29
INDHSPVFRHKEMVL	PCDHB9	126	Q9Y5E1
PNQAFKRLHDLMHFN	PLA2G4A	686	P47712
KRLHDLMHFNTLNNI	PLA2G4A	691	P47712
HQSMVPLLLHLKDQC	MROH5	1166	Q6ZUA9
LIKHSPRVNVVMHFF	FBXL21P	286	Q9UKT6
SHDALHTMKLNQVPL	FAM47E	246	Q6ZV65
DLRQTLPNLKNFMEH	UVRAG	446	Q9P2Y5
EHPLDALRHQTKIMF	THADA	401	Q6YHU6
HEHFNKLMARPAVAL	SOS2	306	Q07890
QFAVHLMPHLLTLAN	PPP4R1	861	Q8TF05
LKELHPFDLHAMQNI	SYNE2	1286	Q8WXH0
DQLMHPKNIHARFLK	TDRD15	1196	B5MCY1
MCNDRNHPKIRSLVH	RFC1	751	P35251
EALTMRQFDHPHIVK	PTK2	471	Q05397
LFNRQPSLHKLSIMA	POLR3A	461	O14802
LRTPDSKQIIANHHM	SHC3	236	Q92529
KIKQIMHHFIPDLLF	SIN3A	811	Q96ST3
HRMPLEFKTLNVLHN	ST8SIA4	331	Q92187
EAHIKSFHMKPILNL	SPATA31D4	901	Q6ZUB0
LNKLMSNLRTTHPHF	MYH3	656	P11055
TFHGLKNLMQLNLAH	PRELP	216	P51888
VRHLQRHILEMNFSK	WIZ	1616	O95785
NLNKLMTNLRTTHPH	MYH6	656	P13533
AIAPRMLADFLTNHK	OR5AR1	76	Q8NGP9
LDNLSHHFLIMGRKV	SFRP1	261	Q8N474
HRHFRLVHNLNFKMP	SGSH	381	P51688
LQHHMLKVALELPAS	URB1	601	O60287
MAFNALIHKHRPDLI	SPTBN1	206	Q01082
QHLHLMVQLLRPQDD	SSH3	96	Q8TE77
EKLPALLFMQQPRHH	CHRNB2	341	P17787
SNFNHRLLEMILNKP	AKR1C2	166	P52895
QMLQHFEHLAPVLVA	NCAPD2	246	Q15021
FPHLVKELNAGLHVM	CLRN2	86	A0PK11
AHLLLKRNPVMFFQH	NCAPD3	1041	P42695
IHLGAQLKTMHNLRL	C12orf4	276	Q9NQ89
TNEPQLVISLHMLHR	NCOA2	361	Q15596
NDHVSKMSRIFNPHL	VGLL4	71	Q14135
FNHMPKIRTLRLHSN	SLIT3	201	O75094
MHRKHLQEIPDLSSN	SKP2	1	Q13309
PLHMGLHKLVVNFES	TGM2	656	P21980
LTHDPLRQKAMFLQS	PITPNM1	1096	O00562
PLLLKDMTFIHEGNH	RAPGEF3	816	O95398
EAHIKSFHMKPILNL	SPATA31D3	901	P0C874
DPKHFHNRVVRIMID	TPTE	291	P56180
DVTHLLLKAMEHFPN	ZYG11B	406	Q9C0D3
AQKPQLLRHMEQHVS	ZFAT	976	Q9P243
LLRHMEQHVSFKPFR	ZFAT	981	Q9P243
DTQHLIKQLRQHFAM	TTC8	526	Q8TAM2
LHTMLLKQEPQRQHL	NAA35	471	Q5VZE5
RKLMLGHNHVQNLPT	PHLPP2	551	Q6ZVD8
RIIHHTSFQEMKNNP	SULT1E1	221	P49888
MKELASLHDKHLNRP	STX16	96	O14662
MSPSQLLEHQELHLK	ZNF574	86	Q6ZN55
MLEALNFLHSKRIIH	STK10	141	O94804
HIGHDMLPNIRESNK	TTBK2	736	Q6IQ55
SIKMNNKPLFLHHVI	TNS1	176	Q9HBL0
LLVHQMRHSGAKPLQ	ZNF276	511	Q8N554
NLMSLKNHRRIHADP	ZNF646	1241	O15015
NHVLFTKEEHMRPFN	NF1	1451	P21359
KEAHLMSKFNHPNIL	ROS1	1996	P08922
SMLSRHLPNLQTHKE	TP53BP1	41	Q12888
NAIIHRHKPLLIDMN	PLEC	331	Q15149
VLNNLKMLLLHHNRF	TLR7	771	Q9NYK1
LSLEMVNFKHPQTHE	TNKS2	351	Q9H2K2
LIQHQRMHTGEKPYE	ZNF829	311	Q3KNS6
SHLPELHMFQTQGKI	ZNF813	146	Q6ZN06
EIHQLMHKLNVNLPR	PLCH1	166	Q4KWH8
LANRLLNFLMKHVFH	PRKDC	2211	P78527
LNFLMKHVFHPKRAV	PRKDC	2216	P78527
LNLDMHQRVHTGEKP	ZNF234	581	Q14588
KNMFERHLQIHLITR	ZNF827	1031	Q17R98
KVLMRNLFIGHFHTP	TRIP11	1781	Q15643
PLKRHEHVQFNEFLM	USP30	336	Q70CQ3
QEFPEHHKMILDRLN	ZNF131	11	P52739
KNLATAFMIIHHPES	TXLNB	501	Q8N3L3
HKIVLPMHSFAQLRD	TRAPPC10	576	P48553
FLDRQELLKHQRMHT	ZNF275	246	Q9NSD4
ELLKHQRMHTGHLPF	ZNF275	251	Q9NSD4
PVQHLFNIREHILMK	ZNF781	296	Q8N8C0
HKRQMQDPQLHSPFS	VENTX	146	O95231
KENAMRLSRIHHDQP	UGT2A2	446	P0DTE5
LKNHLRLHTGDRPFM	ZBTB40	851	Q9NUA8
NPALLRHQRMHTGEK	ZNF662	316	Q6ZS27
PHTHEREINVMLYNK	WDR64	451	B1ANS9
VHHLPQQLKQRMLEY	KCNH8	496	Q96L42
IIRNKLHFPMDIHTL	LRP4	676	O75096
LSNLMRLHIDHNKIE	MXRA5	126	Q9NR99
IGKIIHPQQLMHSFI	NDC1	106	Q9BTX1